Enlivex Therapeutics Ltd (NASDAQ:ENLV)
| 1.54 Delayed Data As of Sep 28 |  +0.08 / +5.33%Today’s Change | 1.36 Today|||52-Week Range 4.92 | -60.89% Year-to-Date |
Latest ENLV News | Press Releases
No recent news for Enlivex Therapeutics Ltd.
Today’s Trading
| Previous close | 1.50 |
| Today’s open | 1.55 |
| Day’s range | 1.54 - 1.58 |
| Volume | 9,962 |
| Average volume (3 months) | 25,880 |
| Market cap | $26.6M |
Data as of 3:45pm ET, 09/28/2023
Growth & Valuation
| Earnings growth (last year) | -108.43% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SIENSientra Inc | +0.18 | +6.92% |
| ---- | ||
| RWLKRewalk Robotics Ltd | +0.03 | +3.40% |
| POAIPredictive Oncology ... | +0.15 | +4.92% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 20, 2023 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$31.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Ness Ziona, Tel Aviv |
Forecasts
